Target intelligence / Profile preview

TMEM167B divergent transcript (TMEM167B-DT)

Target
TMEM167B-DT
Molecular classification
Long non-coding RNA, Divergent transcript
01

Overview

TMEM167B divergent transcript (TMEM167B-DT) is a long non-coding RNA transcribed in the region of the TMEM167B gene. It is produced by divergent transcription—a phenomenon in which the promoter of a protein-coding gene also initiates transcription in the opposite direction, generating non-coding RNA. Such transcripts rarely encode proteins and are typically involved in local gene regulation, especially during development and cell differentiation[2][3]. Divergent transcripts often remain chromatin-associated and are co-expressed with their paired protein-coding gene. While some lncRNAs derived from divergent transcription have described regulatory roles (such as chromatin modification or influencing transcriptional pausing), TMEM167B-DT itself has not been directly tied to specific disease processes, protein interactions, or drug mechanisms. Overall, TMEM167B-DT reflects a growing understanding that many regions of the mammalian genome are pervasively transcribed, often without producing proteins, but may still contribute to complex regulatory networks influencing gene activity and epigenetic states[2][3]. In summary: TMEM167B-DT is a non-coding RNA, not a classical therapeutic target, and is best described as a divergent transcript with potential regulatory roles, but with no direct involvement in known drug interactions or disease pathways[1][2][3].

Other names
TMEM167B-DTTMEM167B divergent transcript
02

Biological functions

Gene regulationCo-regulation of neighboring protein-coding genesPotential modulation of chromatin and transcriptional landscape during cell differentiation and development
03

Disease associations

No strong evidence for direct disease involvement

Beyond the preview

Go deeper on TMEM167B divergent transcript (TMEM167B-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM167B divergent transcript (TMEM167B-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call